Pfizer’s experimental mRNA jab caused one in five children aged 2–5 enrolled in clinical trials to develop severe fevers, data from the company’s own trial shows.
Reporting on his Substack “Unreported Truths,” researcher Alex Berenson highlighted the alarming data released by the company itself to investors last month shows Pfizer is struggling to figure out dosages for the young age group.
“Fevers in kids 2-5 who received 10 micrograms of mRNA were both more common and more severe than those in other children tested with the vaccine, the company found,” Berenson reported, adding the adverse event occurred regardless of first, or second dose tests.
The data appears in slide #23 of a slideshow presentation prepared for analysts and investors on December 17, and shows the 2 to 5 age range was more highly affected than any other group.
While the fevers were observed in the higher dosage, a 10-microgram dose has still been approved by the FDA and CDC for children aged 5 to 12.